Blog

International Neoadjuvant Immunotherapy Across Cancers Congress has been accredited by EACCME – 3P Solution

Photo from 3P Solution/LinkedIn

Jul 9, 2024, 14:34

International Neoadjuvant Immunotherapy Across Cancers Congress has been accredited by EACCME – 3P Solution

3P Solution shared a post on LinkedIn:

“Good news!

I.N.N.O.VA.TE– International Neoadjuvant Immunotherapy Across Cancers Congress, that will be held in Naples, on July 11th and 12th 2024, has been accredited by the European Accreditation Council for Continuing Medical Education (EACCME) for a maximum of 12.0 European CME credits (ECMECs)!

We look forward to meeting you in Naples!”

Source: 3P Solution/LinkedIn

3P Solution cancer EACCME European Accreditation Council for Continuing Medical Education European CME credits INNOVATE International Neoadjuvant Immunotherapy Across Cancers Congress Italy Medical Conference Naples OncoDaily Oncology

Oncologist Near Me - Vivek Subbiah: Pionner of Precision Oncology

Monica Bertagnolli is ending her tenure as NIH director

NEW PAPER ALERT: Efficacy of CDK4/6 Inhibitors and Endocrine Therapy in HR+/HER2- Advanced Breast Cancer by PAM50 Subtype: SOLTI-1801 CDK-PREDICT Results

Oncologist Near Me – Fabrice André: Leading Expert in Breast Cancer

Funding Impactful Cancer Research That Might Otherwise Go Unsupported: Ryan Schoenfeld on the Secret Behind Mark Foundation’s Success